BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11205159)

  • 1. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling.
    Tatton WG; Chalmers-Redman RM; Elstner M; Leesch W; Jagodzinski FB; Stupak DP; Sugrue MM; Tatton NA
    J Neural Transm Suppl; 2000; (60):77-100. PubMed ID: 11205159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.
    Sirover MA
    Biochim Biophys Acta; 1999 Jul; 1432(2):159-84. PubMed ID: 10407139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Properties and functional diversity of glyceraldehyde-3-phosphate dehydrogenase].
    Rodacka A
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():775-89. PubMed ID: 24018444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.
    Carlile GW; Chalmers-Redman RM; Tatton NA; Pong A; Borden KE; Tatton WG
    Mol Pharmacol; 2000 Jan; 57(1):2-12. PubMed ID: 10617673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?
    Mazzola JL; Sirover MA
    Neurotoxicology; 2002 Oct; 23(4-5):603-9. PubMed ID: 12428732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceraldehyde-3-phosphate dehydrogenase and apoptosis.
    Berry MD; Boulton AA
    J Neurosci Res; 2000 Apr; 60(2):150-4. PubMed ID: 10740219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cryoprotectant induces conformational change in glyceraldehyde-3-phosphate dehydrogenase.
    Kim YJ
    Acta Crystallogr F Struct Biol Commun; 2018 May; 74(Pt 5):277-282. PubMed ID: 29717994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in DNA Repair.
    Kosova AA; Khodyreva SN; Lavrik OI
    Biochemistry (Mosc); 2017 Jun; 82(6):643-654. PubMed ID: 28601074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein thiol modification of glyceraldehyde-3-phosphate dehydrogenase as a target for nitric oxide signaling.
    Brüne B; Lapetina EG
    Genet Eng (N Y); 1995; 17():149-64. PubMed ID: 7540026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases.
    Chuang DM; Hough C; Senatorov VV
    Annu Rev Pharmacol Toxicol; 2005; 45():269-90. PubMed ID: 15822178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.
    Tatton W; Chalmers-Redman R; Tatton N
    J Neural Transm (Vienna); 2003 May; 110(5):509-15. PubMed ID: 12721812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis.
    Saunders PA; Chalecka-Franaszek E; Chuang DM
    J Neurochem; 1997 Nov; 69(5):1820-8. PubMed ID: 9349524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection by pharmacologic blockade of the GAPDH death cascade.
    Hara MR; Thomas B; Cascio MB; Bae BI; Hester LD; Dawson VL; Dawson TM; Sawa A; Snyder SH
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3887-9. PubMed ID: 16505364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Role of Glycolytic Enzymes PFKFB3 and GAPDH in the Modulation of Aβ and Neurodegeneration and Their Potential of Therapeutic Targets in Alzheimer's Disease.
    Ahmad I; Singh R; Pal S; Prajapati S; Sachan N; Laiq Y; Husain H
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4673-4688. PubMed ID: 36692648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
    Gregus Z; Németi B
    Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology.
    Sirover MA
    J Cell Biochem; 1997 Aug; 66(2):133-40. PubMed ID: 9213215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells.
    Kusner LL; Sarthy VP; Mohr S
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1553-61. PubMed ID: 15111614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl.
    Medvedev A; Buneeva O; Gnedenko O; Fedchenko V; Medvedeva M; Ivanov Y; Glover V; Sandler M
    J Neural Transm Suppl; 2006; (71):97-103. PubMed ID: 17447420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biological significance of oxidative modifications of cysteine residues in proteins illustrated with the example of glyceraldehyde-3-phosphate dehydrogenase].
    Rodacka A; Gerszon J; Puchała M
    Postepy Hig Med Dosw (Online); 2014 Mar; 68():280-90. PubMed ID: 24662796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.